Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

Keith Maxwell, Senior Product Manager of Exoskeleton Technologies at Lockheed Martin, demonstrates an Exoskeleton during a Exoskeleton demonstration and discussion, in Washington, U.S., Nov. 29, 2018.

ALEXANDER DRAGO/Reuters

The U.S. Army is investing millions of dollars in experimental exoskeleton technology to make soldiers stronger and more resilient, in what experts say is part of a broader push into advanced gear to equip a new generation of “supersoldiers.”

The technology is being developed by Lockheed Martin Corp with a license from Canada-based B-TEMIA, which first developed the exoskeletons to help people with mobility difficulties stemming from medical ailments like multiple sclerosis and severe osteoarthritis.

Worn over a pair of pants, the battery-operated exoskeleton uses a suite of sensors, artificial intelligence and other technology to aid natural movements.

Story continues below advertisement

For the U.S. military, the appeal of such technology is clear: Soldiers now deploy into war zones bogged down by heavy but critical gear like body armour, night-vision goggles and advanced radios. Altogether, that can weigh anywhere from 90 to 140 pounds (40-64 kg), when the recommended limit is just 50 pounds (23 kg).

“That means when people do show up to the fight, they’re fatigued,” said Paul Scharre at the Center for a New American Security (CNAS), who helped lead a series of studies on exoskeletons and other advanced gear.

“The fundamental challenge we’re facing with infantry troops is they’re carrying too much weight.”

Lockheed Martin said on Thursday it won a $6.9-million award from the U.S. Army Natick Soldier Research, Development and Engineering Center to research and develop the exoskeleton, called ONYX, under a two-year, sole-source agreement.

Keith Maxwell, the exoskeleton technologies manager at Lockheed Martin Missiles and Fire Control, said people in his company’s trials who wore the exoskeletons showed far more endurance.

“You get to the fight fresh. You’re not worn out,” Maxwell said.

Maxwell, who demonstrated a prototype, said each exoskeleton was expected to cost in the tens of thousands of dollars.

Story continues below advertisement

B-TEMIA’s medically focused system, called Keeogo, is sold in Canada for about C$39,000 ($30,000), company spokeswoman Pamela Borges said.

The United States is not the only country looking at exoskeleton technology.

Samuel Bendett at the Center for Naval Analyses, a federally funded U.S. research and development centre, said Russia and China were also investing in exoskeleton technologies, “in parallel” to the U.S. advances.

Russia, in particular, was working on several versions of exoskeletons, including one that it tested recently in Syria, Bendett said.

The CNAS analysis of the exoskeleton was part of a larger look by the Washington-based think tank at next-generation technologies that can aid soldiers, from better helmets to shield them from blast injuries to the introduction of robotic “teammates” to help resupply them in war zones.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies